3rd Quarter - Report

FARRAGUT PARTNERS LLP for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Part B and FDA. Cancer Payment Reform Legislation S. 462. Issues related to the 340B Drug discount program. CHIP reauthorization.

LobbyistCovered position, as disclosed
JODY SHINTARO GALE —
JEFF MACKINNON LD & LA Rep. Joe Barton (RTexas)
JEFFERY C. MORTIER Prof Staff on E&C Cmte and LA Rep Whitfield
JOSEPH V VASAPOLI Min. Counsel, Energy&Comm, Special Asst. DOE
J DANIEL WALSH LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner
SARAH WALTER Former Legislative Director/Chief Counsel, Sen. John Breaux

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 462 (115th)

Health Issues HCR

Medicare Part B and FDA. Cancer Payment Reform Legislation S. 462. Issues related to the 340B Drug discount program.

LobbyistCovered position, as disclosed
JEFF MACKINNON Prof Staff on E&C Cmte and LA Rep Whitfield
JEFFERY C. MORTIER LD & LA Rep. Joe Barton (RTexas)
J DANIEL WALSH LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner
SARAH WALTER Former Legislative Director/Chief Counsel, Sen. John Breaux

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 462 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.